NGNE Return on Tangible Equity | Neurogene Inc.

Neurogene Inc. (NGNE) Return on Tangible Equity

2026-06-30: Return Tang Equity -51.17%.
2026-03-31: Return Tang Equity -41.48%.
2025-12-31: Return Tang Equity -34.11%.
2025-09-30: Return Tang Equity -32.06%.

Complete source-backed return tang equity history.

Available history: 2012-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	-51.17%
2026-03-31	-41.48%
2025-12-31	-34.11%
2025-09-30	-32.06%
2025-06-30	-30.88%
2025-03-31	-27.71%
2024-12-31	-24.21%
2024-09-30	-38.75%
2024-06-30	-30.71%
2024-03-31	-23.99%
2023-12-31	-19.52%
2023-09-30	27.17%
2023-06-30	28.55%
2023-03-31	33.06%
2022-12-31	37.87%
2022-09-30	-56.11%
2022-06-30	-52.83%
2022-03-31	-46.99%
2021-12-31	65.97%
2021-09-30	-37.60%
2021-06-30	-26.95%
2021-03-31	-22.15%
2020-12-31	-17.43%
2020-09-30	-14.37%
2020-06-30	-66.77%
2020-03-31	-55.54%
2019-12-31	-49.21%
2019-09-30	-99.96%
2019-06-30	-30.54%
2019-03-31	-26.80%
2018-12-31	-43.46%
2018-09-30	-56.00%
2018-06-30	-43.90%
2018-03-31	-65.82%
2017-12-31	-50.75%
2017-09-30	-39.58%
2017-06-30	-33.28%
2017-03-31	-28.19%
2016-12-31	-25.58%
2016-09-30	-20.22%
2016-06-30	-30.74%
2016-03-31	-21.64%
2015-12-31	-20.16%
2015-09-30	-21.30%
2015-06-30	-98.94%
2015-03-31	-87.13%
2014-12-31	-66.47%
2014-09-30	-44.28%
2014-06-30	-33.10%
2014-03-31	-21.68%
2013-12-31	13.29%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-34.11%
2024-12-31	-24.21%
2023-12-31	-19.52%
2022-12-31	37.87%
2021-12-31	65.97%
2020-12-31	-17.43%
2019-12-31	-49.21%
2018-12-31	-43.46%
2017-12-31	-50.75%
2016-12-31	-25.58%
2015-12-31	-20.16%
2014-12-31	-66.47%
2013-12-31	13.29%
2012-12-31	15.10%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Shattuck Labs, Inc. (STTK)	United States	$0.634B	-13.30
IMPACT BIOMEDICAL INC. (IBO)	United States	$0.611B	66.47
Aquestive Therapeutics, Inc. (AQST)	United States	$0.606B	-6.67
CorMedix Inc. (CRMD)	United States	$0.605B	3.25
BlossomHill Therapeutics, Inc. (BLSM)	United States	$0.647B
CytomX Therapeutics, Inc. (CTMX)	United States	$0.598B	-10.25
Monopar Therapeutics (MNPR)	United States	$0.598B	-34.82
Altimmune, Inc. (ALT)	United States	$0.593B	-6.43
ZEVRA THERAPEUTICS, INC. (ZVRA)	United States	$0.668B	14.61
Phathom Pharmaceuticals, Inc. (PHAT)	United States	$0.572B	-8.76